Drug-induced immune thrombocytopaenia: results from the Berlin Case–Control Surveillance Study (Q33398833)

26 July 2017

title

Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study (English)

1 reference

26 July 2017

Drug-induced immune thrombocytopaenia: results from the Berlin Case–Control Surveillance Study (English)

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

21 December 2024

1 reference

Edeltraut Garbe

1

1 reference

26 July 2017

Frank Andersohn

2

1 reference

26 July 2017

Elisabeth Bronder

3

1 reference

26 July 2017

Abdulgabar Salama

4

1 reference

26 July 2017

Andreas Klimpel

5

1 reference

26 July 2017

Michael Thomae

6

1 reference

26 July 2017

Hubert Schrezenmeier

7

1 reference

26 July 2017

Martin Hildebrandt

8

1 reference

26 July 2017

Ernst Späth-Schwalbe

9

1 reference

26 July 2017

Andreas Grüneisen

10

1 reference

26 July 2017

Oliver Meyer

11

1 reference

26 July 2017

Hanife Kurtal

12

1 reference

26 July 2017

language of work or name

1 reference

21 December 2011

1 reference

full work available at URL

26 July 2017

http://link.springer.com/content/pdf/10.1007/s00228-011-1184-3.pdf

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

http://link.springer.com/article/10.1007/s00228-011-1184-3/fulltext.html

21 December 2024

file format

HyperText Markup Language

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

http://link.springer.com/content/pdf/10.1007/s00228-011-1184-3

21 December 2024

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

European Journal of Clinical Pharmacology

21 December 2024

published in

1 reference

26 July 2017

volume

68

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

821-832

1 reference

Acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Subdural hematoma secondary to immune thrombocytopenic purpura: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Drug-induced immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Drug-induced thrombocytopenia: a systematic review of published case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Drug-induced thrombocytopenia: a population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

The MAIPA assay and its applications in immunohaematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Eptifibatide-associated acute, profound thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Induction and latent periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Vaccination and autoimmune disease: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Estrogen and cyproterone acetate combination-induced autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Drug-induced immune thrombocytopenia

21 January 2018

1 reference

12 December 2020

Acute thrombocytopenic purpura in relation to the use of drugs.

1 reference

12 December 2020

Immune thrombocytopenic purpura following influenza vaccination.

1 reference

12 December 2020

Acute idiopathic thrombocytopenic purpura after anti-influenza vaccination

1 reference

12 December 2020

Thrombocytopenia after immunization of Canadian children, 1992 to 2001.

1 reference

12 December 2020

Drug-induced thrombocytopenia

1 reference

12 December 2020

Trimethoprim-sulphamethoxazole and thrombocytopenia

1 reference

12 December 2020

Delayed immunologic thrombocytopenia induced by abciximab

1 reference

12 December 2020

PROTRACTED THROMBOCYTOPENIA AFTER POLIOMYELITIS IMMUNIZATION: CONTRIBUTION TO THE TREATMENT OF HEMORRHAGIC DIATHESIS

1 reference

12 December 2020

Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient

1 reference

12 December 2020

Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor

1 reference

12 December 2020

Drug-induced thrombocytopenia

1 reference

12 December 2020

Frequency of thrombocytopenia associated with gentamicin therapy

1 reference

12 December 2020

DITP causation: 3 methods better than 1?

1 reference

12 December 2020

Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia.

1 reference

12 December 2020

Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies

1 reference

12 December 2020

Drug-induced thrombocytopenia: pathogenesis, evaluation, and management

1 reference

12 December 2020

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology

1 reference

12 December 2020

Pediatric Infectious Disease Journal

37

22

119

T Jadavji

2003

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

Medicina (Florence, Italy)

21 December 2024

38

9

417

P Casoli

1989

1 reference

https://api.crossref.org/works/10.1007/S00228-011-1184-3

21 December 2024

Identifiers

1 reference

Dimensions Publication ID

26 July 2017

1013425217

0 references

Fatcat ID

release_s7rrx7ovtzbnllmjlrna4htcvq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s7rrx7ovtzbnllmjlrna4htcvq

24 November 2022

mapped directly with Wikidata item

1 reference